Lata Jayaraman

3.1k total citations · 1 hit paper
23 papers, 2.0k citations indexed

About

Lata Jayaraman is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lata Jayaraman has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Lata Jayaraman's work include Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Lata Jayaraman is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Cancer-related gene regulation (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Lata Jayaraman collaborates with scholars based in United States, Italy and Germany. Lata Jayaraman's co-authors include Joan Massagué, Carol Prives, Nikola P. Pavletich, Yanfei Wang, Yigong Shi, Haijuan Yang, Célio Pouponnot, Ashok V. Purandare, Katsuyuki Tamai and Xinbin Chen and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Lata Jayaraman

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal Structure of a Smad MH1 Domain Bound to DNA

1998 594 citations Yigong Shi, Yanfei Wang et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lata Jayaraman United States	16	1.7k	638	215	144	122	23	2.0k
Cornelia Rudolph Germany	18	1.4k 0.8×	523 0.8×	227 1.1×	110 0.8×	76 0.6×	41	2.1k
Shaija Samuel United States	14	972 0.6×	739 1.2×	433 2.0×	70 0.5×	75 0.6×	16	1.5k
Paola Monti Italy	23	987 0.6×	759 1.2×	343 1.6×	87 0.6×	127 1.0×	59	1.4k
Adam D. Steg United States	20	1.2k 0.7×	852 1.3×	431 2.0×	134 0.9×	55 0.5×	44	1.8k
Uta Kossatz-Boehlert Germany	14	951 0.6×	689 1.1×	333 1.5×	100 0.7×	68 0.6×	15	1.4k
Eiji Toyoda Japan	18	1.2k 0.7×	788 1.2×	320 1.5×	106 0.7×	66 0.5×	31	1.8k
Yongping Crawford United States	14	1.1k 0.6×	581 0.9×	450 2.1×	75 0.5×	58 0.5×	16	1.5k
Nikolaos A. Dallas United States	13	889 0.5×	711 1.1×	451 2.1×	78 0.5×	73 0.6×	16	1.4k
Jan van Riggelen United States	17	1.3k 0.8×	483 0.8×	333 1.5×	87 0.6×	43 0.4×	20	1.7k
Mark J. Hynes United States	7	767 0.4×	1.2k 1.9×	502 2.3×	91 0.6×	128 1.0×	9	1.5k

Countries citing papers authored by Lata Jayaraman

Since Specialization

Citations

This map shows the geographic impact of Lata Jayaraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lata Jayaraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lata Jayaraman more than expected).

Fields of papers citing papers by Lata Jayaraman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lata Jayaraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lata Jayaraman. The network helps show where Lata Jayaraman may publish in the future.

Co-authorship network of co-authors of Lata Jayaraman

This figure shows the co-authorship network connecting the top 25 collaborators of Lata Jayaraman. A scholar is included among the top collaborators of Lata Jayaraman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lata Jayaraman. Lata Jayaraman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Velaparthi, Upender, Mark G. Saulnier, David B. Frennesson, et al.. (2022). The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer. Bioorganic & Medicinal Chemistry Letters. 75. 128951–128951. 7 indexed citations

Jayaraman, Lata, Jaclyn Sceneay, Srimathi Srinivasan, et al.. (2019). Abstract B063: Leveraging gut microbiota networks to impact tumor immunotherapy. Cancer Immunology Research. 7(2_Supplement). B063–B063. 1 indexed citations

Kopinja, Johnny E., Raquel Sevilla, Diane Levitan, et al.. (2017). A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit. Scientific Reports. 7(1). 13853–13853. 36 indexed citations

Tian, Xi, Minh Nguyen, Henry P. Foote, et al.. (2016). CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α. Cancer Research. 77(1). 112–122. 72 indexed citations

Jha, Sharda, Erick J. Morris, Alan Hruza, et al.. (2016). Dissecting Therapeutic Resistance to ERK Inhibition. Molecular Cancer Therapeutics. 15(4). 548–559. 39 indexed citations

Pham, Elizabeth, Melissa Yin, Christian Peters, et al.. (2016). Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer. Cancer Research. 76(15). 4493–4503. 55 indexed citations

Krasner, Carolyn, Michael J. Birrer, Christian Peters, et al.. (2016). Abstract CT090: Phase II trial of the NDC CRLX101 in combination with bevacizumab in patients with platinum-resistant ovarian cancer (PROC). Cancer Research. 76(14_Supplement). CT090–CT090. 3 indexed citations

Peters, Christian, Douglas Lazarus, Donna M. Brown, et al.. (2015). Abstract B37: Selective tumor localization of CRLX101, a novel nanoparticle-drug conjugate. Molecular Cancer Therapeutics. 14(12_Supplement_2). B37–B37. 2 indexed citations

O’Keefe, Stephen J., Jean Hoffman‐Censits, Ronac Mamtani, et al.. (2015). HIF inhibition in metastatic renal cell carcinoma (mRCC): Final results of a phase Ib /IIa clinical trial evaluating the nanoparticle drug conjugate (NDC), CRLX101, in combination with bevacizumab (bev).. Journal of Clinical Oncology. 33(15_suppl). 4543–4543. 1 indexed citations

10.

Pedicord, Donna L., Sujatha Nagulapalli, Suhong Pang, et al.. (2010). An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitors. Analytical Biochemistry. 402(1). 65–68. 15 indexed citations

11.

Wan, Honghe, Tram Huynh, Suhong Pang, et al.. (2009). Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)—Hit to Lead studies. Bioorganic & Medicinal Chemistry Letters. 19(17). 5063–5066. 45 indexed citations

12.

Huynh, Tram, Zhong Chen, Suhong Pang, et al.. (2009). Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1). Bioorganic & Medicinal Chemistry Letters. 19(11). 2924–2927. 62 indexed citations

13.

Purandare, Ashok V., Zhong Chen, Tram Huynh, et al.. (2008). Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). Bioorganic & Medicinal Chemistry Letters. 18(15). 4438–4441. 69 indexed citations

14.

Jayaraman, Lata & Joan Massagué. (2000). Distinct Oligomeric States of SMAD Proteins in the Transforming Growth Factor-β Pathway. Journal of Biological Chemistry. 275(52). 40710–40717. 96 indexed citations

15.

Shi, Yigong, Yanfei Wang, Lata Jayaraman, et al.. (1998). Crystal Structure of a Smad MH1 Domain Bound to DNA. Cell. 94(5). 585–594. 594 indexed citations breakdown →

16.

Pouponnot, Célio, Lata Jayaraman, & Joan Massagué. (1998). Physical and Functional Interaction of SMADs and p300/CBP. Journal of Biological Chemistry. 273(36). 22865–22868. 294 indexed citations

17.

Jayaraman, Lata, et al.. (1997). Functional dissection of p53 tumor suppressor protein. Methods in enzymology on CD-ROM/Methods in enzymology. 283. 245–256. 23 indexed citations

18.

Miller, Scott D., Kevin Moses, Lata Jayaraman, & Carol Prives. (1997). Complex Formation between p53 and Replication Protein A Inhibits the Sequence-Specific DNA Binding of p53 and Is Regulated by Single-Stranded DNA. Molecular and Cellular Biology. 17(4). 2194–2201. 48 indexed citations

19.

Shieh, Sheau-Yann, Xinbin Chen, Lata Jayaraman, et al.. (1997). p53 Is Phosphorylated by CDK7-Cyclin H in a p36^MAT1-Dependent Manner. Molecular and Cellular Biology. 17(12). 7220–7229. 151 indexed citations

20.

Jayaraman, Lata & Carol Prives. (1995). Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus. Cell. 81(7). 1021–1029. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact